Natural Product: NPC475234

Natural Product IDNPC475234
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Deglucocyclamin
IUPAC Name n.a.
Synonyms Deglucocyclamin
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL501615
PubChem CID 44566607
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey JXTOWLUQSHIIDP-TYIURIOSSA-N
Standard InCHI InChI=1S/C52H84O22/c1-46(2)27-7-11-49(5)28(8-12-52-29-15-47(3,21-55)13-14-51(29,22-68-52)30(57)16-50(49,52)6)48(27,4)10-9-31(46)72-44-40(74-43-39(65)36(62)33(59)24(17-53)69-43)35(61)26(20-67-44)71-45-41(37(63)34(60)25(18-54)70-45)73-42-38(64)32(58)23(56)19-66-42/h21,23-45,53-54,56-65H,7-20,22H2,1-6H3/t23-,24+,25+,26-,27-,28+,29+,30+,31-,32-,33+,34+,35-,36-,37-,38+,39+,40+,41+,42-,43-,44-,45-,47-,48-,49+,50-,51+,52-/m0/s1
SMILES OC[C@H]1O[C@@H](O[C@H]2[C@@H](OC[C@@H]([C@@H]2O)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O[C@@H]2OC[C@@H]([C@@H]([C@H]2O)O)O)O)O)O[C@H]2CC[C@]3([C@H](C2(C)C)CC[C@@]2([C@@H]3CC[C@]34[C@@]2(C)C[C@H]([C@@]2([C@H]4C[C@@](C)(C=O)CC2)CO3)O)C)C)[C@@H]([C@H]([C@@H]1O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1060.55 Volume:   1013.132
?
Van der Waals volume.
Dense:   1.047 LogP:   -0.149
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   0.691
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.89
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   54.0
TPSA:   342.9
?
Topological Polar Surface Area.
H-Bond Acceptor:   22.0
H-Bond Donor:   12.0 Rings:   10.0
Heavy Atoms:   22.0

MedChem Properties

QED Drug-Likeness Score:   0.079 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.286 Fsp3:   0.981
MCE-18:   283.786
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.891 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.277 Promiscuous compounds:   0.02

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.589 MDCK Permeability:   -5.044
Pgp-inhibitor:   0.0 Pgp-substrate:   0.69
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.812
20% Bioavailability (F20%):   0.558 30% Bioavailability (F30%):   0.999
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.142 MRP1:   0.008
Plasma Protein Binding (PPB):   60.541% Volume Distribution (VD):   -0.387
Fu: 29.499%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.09
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.038
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  -0.28 Half-life (T1/2):  3.1

ADMET: Toxicity

hERG Blockers:  0.003 hERG Blockers (10um):  0.005
Human Hepatotoxicity (H-HT):  0.762 Drug-induced Liver Injury (DILI):  0.914
AMES Toxicity:  0.999 Rat Oral Acute Toxicity:  0.006
Maximum Recommended Daily Dose:  0.001 Skin Sensitization:  1.0
Carcinogencity:  0.246 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.001
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.999
Hematotoxicity:  0.884 Drug-induced Nephrotoxicity:  0.968
Genotoxicity:  0.955 RPMI-8226 Immunitoxicity:  0.367
A549 Cytotoxicity:  0.985 Hek293 Cytotoxicity:  0.885
BCF:   0.981
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.489
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.146
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.204
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15237 Cyclamen mirabile Species Primulaceae Eukaryota n.a. n.a. n.a. PMID[9090874]
NPO15237 Cyclamen mirabile Species Primulaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO15237 Cyclamen mirabile Species Primulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT188 Organism Candida parapsilosis Candida parapsilosis MIC = 80.0 ug.mL-1 PMID[22472691]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 36.7 10'-6M PMID[9090874]
NPT20 Organism Candida albicans Candida albicans MIC = 160.0 ug.mL-1 PMID[19783432]
NPT3153 Organism Kluyveromyces marxianus Kluyveromyces marxianus MIC = 160.0 ug.mL-1 PMID[22472691]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans MIC = 80.0 ug.mL-1 PMID[20739103]
NPT187 Organism Issatchenkia orientalis Pichia kudriavzevii MIC > 320.0 ug.mL-1 PMID[19921834]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 400.0 ug.mL-1 PMID[20017491]
NPT19 Organism Escherichia coli Escherichia coli MIC > 400.0 ug.mL-1 PMID[24479418]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC > 400.0 ug.mL-1 PMID[18077363]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 400.0 ug.mL-1 PubChem BioAssay data set
NPT186 Organism Candida tropicalis Candida tropicalis MIC = 160.0 ug.mL-1 PMID[12662097]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC475234 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC138219
0.949 High Similarity NPC473688
0.9192 High Similarity NPC475630
0.9082 High Similarity NPC77717
0.899 High Similarity NPC40716
0.8846 High Similarity NPC262567
0.875 High Similarity NPC158051
0.8519 High Similarity NPC231566
0.85 High Similarity NPC119628
0.8235 Intermediate Similarity NPC253611
0.8235 Intermediate Similarity NPC488782
0.8113 Intermediate Similarity NPC51579
0.8077 Intermediate Similarity NPC471373
0.8019 Intermediate Similarity NPC471375
0.7981 Intermediate Similarity NPC267238
0.798 Intermediate Similarity NPC18724
0.7895 Intermediate Similarity NPC471431
0.789 Intermediate Similarity NPC205129
0.7885 Intermediate Similarity NPC158367
0.7778 Intermediate Similarity NPC209798
0.7748 Intermediate Similarity NPC471425
0.7723 Intermediate Similarity NPC224003
0.7679 Intermediate Similarity NPC189575
0.767 Intermediate Similarity NPC323231
0.7611 Intermediate Similarity NPC471429
0.757 Intermediate Similarity NPC157571
0.7565 Intermediate Similarity NPC471427
0.7478 Intermediate Similarity NPC106701
0.7436 Intermediate Similarity NPC471626
0.7431 Intermediate Similarity NPC273189
0.7407 Intermediate Similarity NPC148593
0.7364 Intermediate Similarity NPC471374
0.7265 Intermediate Similarity NPC471426
0.7168 Intermediate Similarity NPC126753
0.7103 Intermediate Similarity NPC171741
0.6847 Remote Similarity NPC207693
0.6847 Remote Similarity NPC470623
0.6833 Remote Similarity NPC471424
0.6726 Remote Similarity NPC184805
0.6613 Remote Similarity NPC471428
0.6348 Remote Similarity NPC87393
0.6341 Remote Similarity NPC22709
0.629 Remote Similarity NPC471430
0.6198 Remote Similarity NPC470622
0.5887 Remote Similarity NPC66513
0.5868 Remote Similarity NPC185466
0.582 Remote Similarity NPC607904
0.5798 Remote Similarity NPC606145
0.5702 Remote Similarity NPC609281
0.5691 Remote Similarity NPC610204
0.5691 Remote Similarity NPC610461
0.568 Remote Similarity NPC603137
0.5678 Remote Similarity NPC267637
0.5556 Remote Similarity NPC609305
0.5528 Remote Similarity NPC606553
0.5289 Remote Similarity NPC123796
0.5271 Remote Similarity NPC475140
0.5079 Remote Similarity NPC207738

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475234 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data